WILLIAM JOHNSON: Open Payments
NPI 1821570987 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 57 payments from 17 companies in 2025. Trend: 2023 $875 · 2024 $986 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $302 |
| Merck Sharp & Dohme LLC | 10 | $182 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $181 |
| Solventum Corporation | 1 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| ABIOMED | 2 | $60 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| Boston Scientific Corporation | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $34 |
Products named: VERQUVO, LifeVest, V.A.C.ULTA, COBENFY, ELIQUIS, Kerendia, CAMZYOS, JARDIANCE.
Industry payments across IN — which companies pay providers there.
